RSV vaccine in adults aged 60+
Participants needed: Age 60+
What is the purpose of this study?
This study is being done to test a new investigational vaccine which has not yet been approved for general use by Health Canada. The vaccine being tested in this study is made to prevent infection from the respiratory syncytial virus (RSV) in older adults.
RSV is a cold-like germ that affects the airway and lungs. A person with a mild RSV illness may have a cold-like symptoms, such as a cough, sore throat, stuffy/runny nose, and fever. A person with severe RSV illness may have problems breathing. RSV infection can lead to more severe illnesses, such as a lung infection or respiratory failure. Older adults have a higher risk of getting a severe RSV infection than younger adults. There is currently no specific treatment or vaccine against RSV in adults. Therefore, this investigational vaccine is being produced to protect older adults from RSV infection.
Am I Eligible?
You can take part in this study if you are:
- 60 years of age or above,
- Medically stable,
- Able and willing to comply with the requirements of the study.
What Will I Have To Do?
If you choose to participate in this study, you will be asked to review the consent form at the bottom of the page. During your initial visit, you will receive a copy of the completed consent form to keep. The study activities are divided into 2 parts: 1) General study activities that will occur for all participants and 2) Activities that will happen only when you have cold-like symptoms.
Participation in this study involves 5 scheduled visits over a 3 year time period. This is for 3 RSV seasons when the virus is most present. Each year this ranges from October 1st to April 30th. In addition, there will be 3 contacts by study staff that will be done by phone or e-mail. During these contacts, we will ask questions about your health. The total estimated time commitment to participate in this study is 10.5 hours.
NOTE: We ask that you review the information and consent form before volunteering for this study. After review, please contact us. The information and consent form will be reviewed with you during your first site visit before signing.